Imaging Recommendations for Diagnosis, Staging and Management of Treatment-Related Complications in Cancer

Abstract

Precision medicine is becoming increasingly common in oncology, with treatments tailored to individual patients and cancer. By integrating these underlying concepts of health care, chemotherapy and radiotherapy can be tailored to improve safety and efficacy. On the other hand, oncology treatment regimens may result in local and systemic changes and complications depending on the type of treatment. For the proper and prompt management of cancer patients, it is essential to interpret this posttreatment imaging correctly. This article aims at guiding treating physicians to be able to distinguish complications from expected posttreatment changes.

Keywords

complications - oncology - radiology - review

Publikationsverlauf

Artikel online veröffentlicht:
01. März 2023

• References

• 1 Badalamenti G, Messina C, De Luca I, Musso E, Casarin A, Incorvaia L. Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives. Radiol Med (Torino) 2019; 124 (04) 259-265
• 2 Kucha N, Soni TP, Jakhotia N. et al. A prospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients. Cancer Treat Res Commun 2020; 25: 100223
• 3 Ngo D, Jia JB, Green CS, Gulati AT, Lall C. Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective. Insights Imaging 2015; 6 (06) 665-677
• 4 Stone JB, DeAngelis LM. Cancer-treatment-induced neurotoxicity–focus on newer treatments. Nat Rev Clin Oncol 2016; 13 (02) 92-105
• 5 Jairam V, Lee V, Park HS. et al. Treatment-related complications of systemic therapy and radiotherapy. JAMA Oncol 2019; 5 (07) 1028-1035
• 6 Thompson JA, Schneider BJ, Brahmer J. et al. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2022; 20 (04) 387-405
• 7 Baden LR, Swaminathan S, Angarone M. et al. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016; 14 (07) 882-913
• 8 NCG palliative care guidelines 2021 [Internet]. NCG; 2021. . Accessed April 1, 2022, at: https://tmc.gov.in/ncg/index.php/guidelines/palliative-care-guidelines
• 9 NCG. Approach to managing malignant bowel obstruction [Internet]. NCG Guidelines for palliative care. 2021 . Accessed April 1, 2022, at: https://tmc.gov.in/ncg/images/Approach%20to%20managing%20Malignant%20Bowel%20Obstruction.pdf
• 10 Kanda T, Wakabayashi Y, Zeng F. et al. Imaging findings in radiation therapy complications of the central nervous system. Jpn J Radiol 2018; 36 (09) 519-527
• 11 Albano D, Benenati M, Bruno A. et al; Young SIRM Working Group. Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe. Insights Imaging 2021; 12 (01) 76
• 12 Kessler AT, Bhatt AA. Brain tumour post-treatment imaging and treatment-related complications. Insights Imaging 2018; 9 (06) 1057-1075
• 13 Shah R, Vattoth S, Jacob R. et al. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics 2012; 32 (05) 1343-1359
• 14 Leao DJ, Craig PG, Godoy LF, Leite CC, Policeni B. Response assessment in neuro-oncology criteria for gliomas: practical approach using conventional and advanced techniques. AJNR Am J Neuroradiol 2020; 41 (01) 10-20
• 15 Chukwueke UN, Wen PY. Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice. CNS Oncol 2019; 8 (01) CNS28
• 16 Linhares P, Carvalho B, Figueiredo R, Reis RM, Vaz R. Early pseudoprogression following chemoradiotherapy in glioblastoma patients: the value of RANO evaluation. J Oncol 2013; 2013: 690585
• 17 Dietrich J, Klein JP. Imaging of cancer therapy–induced central nervous system toxicity. Neurol Clin [Internet]. 2014. Accessed December 13, 2022, at: https://www.neurologic.theclinics.com/article/S0733-8619(13)00087-X/abstract
• 18 Sindhwani G, Arora M, Thakker VD, Jain A. MRI in chemotherapy induced leukoencephalopathy: report of two cases and radiologist's perspective. J Clin Diagn Res 2017; 11 (07) TD08-TD09
• 19 Glastonbury CM, Parker EE, Hoang JK. The postradiation neck: evaluating response to treatment and recognizing complications. AJR Am J Roentgenol 2010; 195 (02) W164-71
• 20 Gehani A, Sen S, Chatterjee S, Mukhopadhyay S. Imaging features of postradiotherapy changes in head and neck cancers. Indian J Radiol Imaging 2021; 31 (03) 661-669
• 21 Nishino M, Ramaiya NH, Awad MM. et al. PD-1 inhibitor-related pneumonitis in advanced cancer patients: radiographic patterns and clinical course. Clin Cancer Res 2016; 22 (24) 6051-6060
• 22 Terbuch A, Tiu C, Candilejo IM. et al. Radiological patterns of drug-induced interstitial lung disease (DILD) in early-phase oncology clinical trials. Clin Cancer Res 2020; 26 (18) 4805-4813
• 23 Weber JS, Kähler KC, Hauschild A. Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol 2012; 30 (21) 2691-2697
• 24 Lee H, Lee HY, Sun J-M. et al. Transient asymptomatic pulmonary opacities during osimertinib treatment and its clinical implication. J Thorac Oncol 2018; 13 (08) 1106-1112
• 25 Benveniste MF, Gomez D, Carter BW. et al. Recognizing radiation therapy-related complications in the chest. Radiographics 2019; 39 (02) 344-366
• 26 Yeh ETH, Tong AT, Lenihan DJ. et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004; 109 (25) 3122-3131
• 27 Čelutkienė J, Pudil R, López-Fernández T. et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Eur J Heart Fail 2020; 22 (09) 1504-1524
• 28 Whitlock MC, Yeboah J, Burke GL, Chen H, Klepin HD, Hundley WG. Cancer and its association with the development of coronary artery calcification: an assessment from the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2015; 4 (11) e002533
• 29 Wang DY, Salem J-E, Cohen JV. et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol 2018; 4 (12) 1721-1728
• 30 Gatti M, Calandri M, Bergamasco L. et al. Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia. Radiol Med (Torino) 2020; 125 (04) 348-355
• 31 Vernuccio F, Godfrey D, Meyer M. et al. Local tumor control and patient outcome using stereotactic body radiation therapy for hepatocellular carcinoma: iRECIST as a potential substitute for traditional criteria. AJR Am J Roentgenol 2019; 213 (06) 1232-1239
• 32 Hennedige TP, Hallinan JTPD, Leung FP. et al. Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions. Eur Radiol 2016; 26 (02) 398-406
• 33 UpToDate [Internet]. Accessed April 1, 2022, at: https://www.uptodate.com/contents/chemotherapy-and-radiation-related-hemorrhagic-cystitis-in-cancer-patients
• 34 Hutchins TA, Peckham M, Shah LM. et al; Expert Panel on Neurological Imaging. ACR Appropriateness Criteria® low back pain: 2021 update. J Am Coll Radiol 2021; 18 (11S, Supplement): S361-S379
• 35 Kransdorf MJ, Murphey MD, Wessell DE. et al; Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria^® soft-tissue masses. J Am Coll Radiol 2018; 15 (5S): S189-S197
• 36 Shah LM, Jennings JW, Kirsch CFE. et al; Expert Panels on Neurological Imaging, Interventional Radiology, and Musculoskeletal Imaging. ACR Appropriateness Criteria^® management of vertebral compression fractures. J Am Coll Radiol 2018; 15 (11S): S347-S364
• 37 Lee CH, Dershaw DD, Kopans D. et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010; 7 (01) 18-27
• 38 Bevers TB, Anderson BO, Bonaccio E. et al; National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009; 7 (10) 1060-1096
• 39 Johnson CB, Sulpher J, Stadnick E. Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians. Curr Opin Cardiol 2015; 30 (02) 197-204
• 40 Huang H, Nijjar PS, Misialek JR. et al. Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2017; 19 (01) 34